Literature DB >> 30261390

Transradial Mechanical Thrombectomy for Proximal Middle Cerebral Artery Occlusion in a First Trimester Pregnancy: Case Report and Literature Review.

Sumedh S Shah1, Brian M Snelling2, Marie Christine Brunet1, Samir Sur1, David J McCarthy1, Alan Stein1, Priyank Khandelwal1, Robert M Starke3, Eric C Peterson4.   

Abstract

BACKGROUND: Acute ischemic stroke in pregnancy is a cause of maternal and fetal morbidity. Optimal treatment strategies for stroke in this population are undefined. Thrombolysis is recommended by guidelines should the benefit outweigh uterine bleeding risk. Alternately, data regarding mechanical thrombectomy (MT) is extremely limited. We present a 37-year-old woman in the first trimester that developed recurrent proximal middle cerebral artery (MCA) occlusion after previous thrombolysis and underwent MT via transradial access. This report of transradial MT represents the first case performed through an extrafemoral route for large vessel occlusion in early pregnancy found in the literature. CASE DESCRIPTION: A 37-year-old gravida 8 para 7 at 9 weeks' gestation presented with left-sided hemiplegia and right gaze preference and underwent successful thrombolysis for a right MCA occlusion. Two days later, she exhibited the same symptoms, and a reoccluded right MCA was identified. Because thrombolysis was unavailable given the recent stroke, the patient underwent emergent MT via radial access (to minimize fetal radiation exposure) and achieved thrombolysis in cerebral infarction 2b revascularization without complication to her or her child. At 2-month follow-up, the patient is on anticoagulation and has a healthy pregnancy with only minor left-sided facial weakness.
CONCLUSIONS: When thrombolysis is contraindicated, thrombectomy should be considered and weighed against risks of fetal radiation exposure and contrast load, especially in early pregnancy. Transradial MT is safe, feasible, and mitigates pelvic radiation. A multidisciplinary approach with obstetrics, stroke teams, and neurointerventionalists is vital for successful therapy.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Mechanical thrombectomy; Pregnancy; Transradial access

Mesh:

Year:  2018        PMID: 30261390     DOI: 10.1016/j.wneu.2018.09.095

Source DB:  PubMed          Journal:  World Neurosurg        ISSN: 1878-8750            Impact factor:   2.104


  6 in total

Review 1.  Maternal Stroke: an Update.

Authors:  Maria D Zambrano; Eliza C Miller
Journal:  Curr Atheroscler Rep       Date:  2019-06-22       Impact factor: 5.113

2.  Comparison of transradial and transfemoral access for the Woven EndoBridge embolization of intracranial aneurysms: A single-center experience.

Authors:  Nimer Adeeb; Mahmoud Dibas; Abdallah Amireh; Sandeep Kandregula; Hugo Cuellar
Journal:  Interv Neuroradiol       Date:  2021-09-22       Impact factor: 1.764

3.  European Stroke Organisation guidelines on stroke in women: Management of menopause, pregnancy and postpartum.

Authors:  Christine Kremer; Zuzana Gdovinova; Yannick Bejot; Mirjam R Heldner; Susanna Zuurbier; Silke Walter; Avtar Lal; Corina Epple; Svetlana Lorenzano; Marie-Luise Mono; Theodore Karapanayiotides; Kailash Krishnan; Dejana Jovanovic; Jesse Dawson; Valeria Caso
Journal:  Eur Stroke J       Date:  2022-03-29

Review 4.  Ischemic stroke and cerebral venous sinus thrombosis in pregnancy.

Authors:  Hannah J Roeder; Jean Rodriguez Lopez; Eliza C Miller
Journal:  Handb Clin Neurol       Date:  2020

Review 5.  Management of Maternal Stroke and Mitigating Risk.

Authors:  Mariel G Kozberg; Erica C Camargo
Journal:  Curr Treat Options Cardiovasc Med       Date:  2019-11-21

6.  Transradial access for flow diversion of intracranial aneurysms: Case series.

Authors:  Muhammad Waqas; Kunal Vakharia; Rimal H Dossani; Gary B Rajah; Michael K Tso; Andrew D Gong; Kyungduk Rho; Hamid H Rai; Kenneth V Snyder; Elad I Levy; Adnan H Siddiqui; Jason M Davies
Journal:  Interv Neuroradiol       Date:  2020-07-05       Impact factor: 1.610

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.